Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01625507
Other study ID # RES0013109
Secondary ID
Status Completed
Phase Phase 2
First received June 19, 2012
Last updated August 9, 2015
Start date October 2012
Est. completion date December 2013

Study information

Verified date July 2015
Source University of Alberta
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The study hypothesis is that individuals with type 2 diabetes (T2D), who adhere to the PANDA intervention, will have improved compliance with the nutritional therapy recommendations of the Canadian Diabetes Association. Specific objectives of this proposal: The objectives of the investigators PANDA (Physical Activity and Nutrition for Diabetes in Alberta) are to (a) to devise and evaluate the efficacy of a multi-level, practical, nutrition intervention program that promotes the individual factors required for effective self-management practices AND that explicitly incorporate strategies to improve food availability, accessibility and acceptability and (b) to use these interventions as a means to examine the relationships between food availability, accessibility, acceptability, adherence to Nutrition Therapy Guidelines, and metabolic indicators of diabetes control in people with type 2 diabetes.


Recruitment information / eligibility

Status Completed
Enrollment 73
Est. completion date December 2013
Est. primary completion date October 2013
Accepts healthy volunteers No
Gender Both
Age group 35 Years to 80 Years
Eligibility Inclusion Criteria:

- Type 2 diabetes, and speak/write English.

- Have attended a diabetes education session delivered by their healthcare provider.

Exclusion Criteria:

- Participants with type 1 diabetes, and those who are unable to speak English.

- People with end-stage renal disease or gastrointestinal diseases that require specialized diets will also be excluded.

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
PANDA intervention
Participants will follow a menu plan and receive training in how to manage their diet in type 2 diabetes, following the recommendations of the Canadian Diabetes Association, 2008

Locations

Country Name City State
Canada Alberta Diabetes Institute Edmonton Alberta

Sponsors (1)

Lead Sponsor Collaborator
University of Alberta

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Total Energy Intake Measured using repeated 24 hour dietary recalls (pre and post-intervention) 4 months No
Primary Change in Macronutrient Intake Measured using repeated 24 hour dietary recalls (pre and post-intervention) 3 months No
Primary Change in Nutrient Intake Measured using repeated 24 hour dietary recalls (pre and post-intervention) 3 months No
Secondary Change in Hemoglobin A1c a surrogate of blood glucose control 4 months No
Secondary Program Retention attendance at meetings 3 months No
Secondary Change in Body Mass Index Actual weight and height used to calculate BMI pre- and post-intervention 4 months No
Secondary Body Composition body fat and fat-free mass 3 months No
Secondary Change in Blood Biomarkers blood lipids: triglyceride, total cholesterol, LDL-cholesterol, HDL-cholesterol 4 months No
Secondary Change in Perceived Dietary Adherence Questionnaire Score Questionnaire assessing self-reported adherence to 9 criteria, whose individual scores (range 0-7) are summed to get the total score. Maximum total score is 63. Minimum total score is 0. A higher score means higher dietary adherence. 4 months No
Secondary Food Acceptability questionnaire based on items related to personal and cultural acceptability of the recommended diet 4 months No
Secondary Food Accessibility questionnaire of items related to financial and physical accessibility of foods in the diet recommended for diabetes 4 months No
Secondary Food Availability questionnaire of items related to the availability in local stores of the food items recommended in the diet for diabetes. 4 months No
Secondary Change in Waist Circumference Measured using repeated 24 hour dietary recalls (pre and post-intervention 4 months No
See also
  Status Clinical Trial Phase
Completed NCT05219994 - Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum N/A
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Completed NCT02284893 - Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone Phase 3
Completed NCT04274660 - Evaluation of Diabetes and WELLbeing Programme N/A
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Active, not recruiting NCT05566847 - Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Completed NCT04965506 - A Study of IBI362 in Chinese Patients With Type 2 Diabetes Phase 2
Recruiting NCT06115265 - Ketogenic Diet and Diabetes Demonstration Project N/A
Active, not recruiting NCT03982381 - SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes Phase 4
Completed NCT04971317 - The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages N/A
Completed NCT04496154 - Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood N/A
Completed NCT04023539 - Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05530356 - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Completed NCT04097600 - A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets Phase 1
Completed NCT03960424 - Diabetes Management Program for Hispanic/Latino N/A
Completed NCT05378282 - Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
Active, not recruiting NCT06010004 - A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Phase 3
Completed NCT03653091 - Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes N/A